港股異動丨紅星美凱龍(1528.HK)尾盤拉昇漲7% 市值重回200億港元上方
格隆匯6月21日丨紅星美凱龍(1528.HK)尾盤漲幅擴大至7%,現報5.2港元創逾4個月新高價,總市值超200億港元。近日,中國連鎖經營協會發布“2020中國連鎖百強”榜單,家居零售龍頭紅星美凱龍以1080.19億元的銷售規模穩居前三甲,繼續蟬聯家居連鎖企業TOP1。數據顯示,百強整體銷售在2020年首次實現負增長。不過,紅星美凱龍在輕資產、重運營、降杆杆的戰略指導下,公司業績逆勢增長。在今年一季度,公司多項數據實現同比大幅增長,展現出強勁復甦勢頭。分析人士指出,隨着疫情影響消退,家居行業的復甦態勢有望持續。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.